A month has passed since Texas Instruments (TXN) revealed their latest earnings report, and its shares have added about 5.0% in that time frame, which is a modest showing for the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Texas Instruments (TXN) due for a negative rebound? Before we dive into how investors and analysts have reacted as of late, let’s take a quick look at its most recent earnings report to get a better handle on its future trend.
Will Texas Instruments (TXN) Continue To Trend Upward?
Texas Instruments (TXN) reported first-quarter 2020 earnings of $1.24 per share, and it reported $3.33 billion net revenue. The top line also came within management’s guided range of $3.12-$3.38 billion.
In respective comparison to the Zacks Consensus estimate, Texas Instruments (TXN) had a 23% advantage for the first quarter and 4.6% advantage in reported revenues.
Furthermore, the COVID outbreak has brought everything to a standstill, especially with the essential Chinese factories.
Although many expressed their fears that the ripple effects of the COVID outbreak will have a lasting and permanent impact on the market, the company witnessed high demand in March, which continued through early April due to customers’ apprehensions regarding the procurement of medical supplies during the Coronavirus standstill.
Texas Instruments (TXN) is not immune to the Coronavirus standstill, but its an example of how some companies can survive based on its substantial investments in new growth, and its ongoing research and development program.
The company, and experts with a close watch, continually express confidence in the portfolio of its long-lived products and efficient manufacturing. Shareholders are going to help the stock rebound for the near foreseeable future.
